Feed excerpt — reported by STAT News
While deaths appear unrelated to Artiva's therapy, they highlight risks as companies seek to apply cancer therapy strategies to autoimmune diseases.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →